Jiang, Linlin <br/><br/>
A novel antibody-drug conjugate anti-CD19(Fab)-LDM in the treatment of B-cell non-Hodgkin lymphoma xenografts with enhanced anticancer activity.  [electronic resource] 

 -  Journal of drug targeting  2016 
 - 47-57 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2330 
<br/><br/><label>Standard No.: </label>10.3109/1061186X.2015.1055568  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--administration & dosage<br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antigens, CD19--immunology<br/>Apoptosis<br/>Cell Line, Tumor<br/>Cell Survival<br/>Dose-Response Relationship, Drug<br/>Drug Carriers<br/>Enediynes--administration & dosage<br/>Female<br/>Heterografts<br/>Humans<br/>Lymphoma, B-Cell--physiopathology<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Recombinant Fusion Proteins--administration & dosage